Connection

Co-Authors

This is a "connection" page, showing publications co-authored by IGNACIO IVAN WISTUBA and ANIRBAN MAITRA.
Connection Strength

1.389
  1. The V599E BRAF mutation is uncommon in biliary tract cancers. Mod Pathol. 2004 Nov; 17(11):1386-91.
    View in: PubMed
    Score: 0.062
  2. Defining precancer: a grand challenge for the cancer community. Nat Rev Cancer. 2024 Nov; 24(11):792-809.
    View in: PubMed
    Score: 0.062
  3. Loss of p53 and SMAD4 induces adenosquamous subtype pancreatic cancer in the absence of an oncogenic KRAS mutation. Cell Rep Med. 2024 Sep 17; 5(9):101711.
    View in: PubMed
    Score: 0.062
  4. Genetic Deletion of Galectin-3 Inhibits Pancreatic Cancer Progression and Enhances the Efficacy of Immunotherapy. Gastroenterology. 2024 Jul; 167(2):298-314.
    View in: PubMed
    Score: 0.060
  5. Progression of gene hypermethylation in gallstone disease leading to gallbladder cancer. Ann Surg Oncol. 2003 Oct; 10(8):882-9.
    View in: PubMed
    Score: 0.058
  6. Identification of novel cellular targets in biliary tract cancers using global gene expression technology. Am J Pathol. 2003 07; 163(1):217-29.
    View in: PubMed
    Score: 0.057
  7. High resolution chromosome 3p, 8p, 9q and 22q allelotyping analysis in the pathogenesis of gallbladder carcinoma. Br J Cancer. 2002 Aug 12; 87(4):432-40.
    View in: PubMed
    Score: 0.053
  8. Fragile histidine triad gene abnormalities in the pathogenesis of gallbladder carcinoma. Am J Pathol. 2002 Jun; 160(6):2073-9.
    View in: PubMed
    Score: 0.053
  9. Diminished Immune Surveillance during Histologic Progression of Intraductal Papillary Mucinous Neoplasms Offers a Therapeutic Opportunity for Cancer Interception. Clin Cancer Res. 2022 05 02; 28(9):1938-1947.
    View in: PubMed
    Score: 0.052
  10. Combined IL-2, agonistic CD3 and 4-1BB stimulation preserve clonotype hierarchy in propagated non-small cell lung cancer tumor-infiltrating lymphocytes. J Immunother Cancer. 2022 02; 10(2).
    View in: PubMed
    Score: 0.051
  11. High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele loss. Am J Pathol. 2001 Jul; 159(1):119-30.
    View in: PubMed
    Score: 0.049
  12. Genome-wide allelotyping analysis reveals multiple sites of allelic loss in gallbladder carcinoma. Cancer Res. 2001 May 01; 61(9):3795-800.
    View in: PubMed
    Score: 0.049
  13. Overexpression of CD73 in pancreatic ductal adenocarcinoma is associated with immunosuppressive tumor microenvironment and poor survival. Pancreatology. 2021 Aug; 21(5):942-949.
    View in: PubMed
    Score: 0.049
  14. Microdissection and the study of cancer pathways. Curr Mol Med. 2001 Mar; 1(1):153-62.
    View in: PubMed
    Score: 0.048
  15. Molecular changes in the bronchial epithelium of patients with small cell lung cancer. Clin Cancer Res. 2000 Jul; 6(7):2604-10.
    View in: PubMed
    Score: 0.046
  16. Plasma-Derived Extracellular Vesicles Convey Protein Signatures that Reflect Pathophysiology in Lung and Pancreatic Adenocarcinomas. Cancers (Basel). 2020 May 02; 12(5).
    View in: PubMed
    Score: 0.046
  17. Molecular abnormalities associated with secretory carcinomas of the breast. Hum Pathol. 1999 Dec; 30(12):1435-40.
    View in: PubMed
    Score: 0.044
  18. Expression of Epithelial-Mesenchymal Transition Markers in Treated Pancreatic Ductal Adenocarcinoma. Pancreas. 2019 Nov/Dec; 48(10):1367-1372.
    View in: PubMed
    Score: 0.044
  19. Allelic losses at chromosome 3p are seen in human papilloma virus 16 associated transitional cell carcinoma of the cervix. Gynecol Oncol. 1999 Sep; 74(3):361-8.
    View in: PubMed
    Score: 0.044
  20. Characterization and Comparison of GITR Expression in Solid Tumors. Clin Cancer Res. 2019 11 01; 25(21):6501-6510.
    View in: PubMed
    Score: 0.043
  21. Enrichment of epithelial cells for molecular studies. Nat Med. 1999 Apr; 5(4):459-63.
    View in: PubMed
    Score: 0.042
  22. METTL13 Methylation of eEF1A Increases Translational Output to Promote Tumorigenesis. Cell. 2019 01 24; 176(3):491-504.e21.
    View in: PubMed
    Score: 0.042
  23. A Functional Spatial Analysis Platform for Discovery of Immunological Interactions Predictive of Low-Grade to High-Grade Transition of Pancreatic Intraductal Papillary Mucinous Neoplasms. Cancer Inform. 2018; 17:1176935118782880.
    View in: PubMed
    Score: 0.040
  24. Dynamic changes during the treatment of pancreatic cancer. Oncotarget. 2018 Mar 13; 9(19):14764-14790.
    View in: PubMed
    Score: 0.039
  25. Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients. Ann Oncol. 2018 01 01; 29(1):223-229.
    View in: PubMed
    Score: 0.039
  26. Prognostic Significance of Tumor-Infiltrating Lymphocytes in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Chemotherapy. Pancreas. 2017 10; 46(9):1180-1187.
    View in: PubMed
    Score: 0.038
  27. High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients. Ann Oncol. 2017 04 01; 28(4):741-747.
    View in: PubMed
    Score: 0.037
  28. Frequent detection of infectious xenotropic murine leukemia virus (XMLV) in human cultures established from mouse xenografts. Cancer Biol Ther. 2011 Oct 01; 12(7):617-28.
    View in: PubMed
    Score: 0.025
  29. Molecular changes in second primary lung and breast cancers after therapy for Hodgkin's disease. Cancer Epidemiol Biomarkers Prev. 2000 Oct; 9(10):1027-35.
    View in: PubMed
    Score: 0.012
  30. Use of archival fine-needle aspirates for the allelotyping of tumors. Cancer. 1999 Dec 25; 87(6):372-9.
    View in: PubMed
    Score: 0.011
  31. Multiple clonal abnormalities in the bronchial epithelium of patients with lung cancer. J Natl Cancer Inst. 1999 Nov 03; 91(21):1863-8.
    View in: PubMed
    Score: 0.011
  32. Multiple regions of chromosome 4 demonstrating allelic losses in breast carcinomas. Cancer Res. 1999 Aug 01; 59(15):3576-80.
    View in: PubMed
    Score: 0.011
  33. Loss of heterozygosity at 3p in benign lesions preceding invasive breast cancer. J Surg Res. 1999 May 01; 83(1):13-8.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.